Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reade is a leading center of expertise for rehabilitation medicine and rheumatology based in Amsterdam, Netherlands. Formed by the merger of the Jan van Breemen Instituut and Revalidatiecentrum Amsterdam, the organization provides specialized medical care and therapy for patients with complex musculoskeletal diseases and physical disabilities. Reade integrates clinical practice with extensive scientific research, focusing on improving treatment outcomes in inflammatory arthritis and neurorehabilitation. The institute serves as a major regional hub for biological therapies and comprehensive rehabilitation programs for spinal cord and brain injuries. It operates as a foundation, collaborating closely with academic institutions to advance medical protocols and patient quality of life.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reade Jan van Breemen Instituut.